MedTrace Logo

Remifentanil Versus Dexmedetomidine for Post-Cardiac Surgery Patients With Noninvasive Ventilation Intolerance

NCT03395886 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 90

Last updated 2019-11-29

Study results available
· View outcomes & findings →

Summary

The aim of this study is to compare the sedation effects between remifentanil and dexmedetomidine in post-cardiac surgical patients who developed noninvasive ventilation (NIV) intolerance.

Conditions

  • Cardiac Surgery

Interventions

DRUG

Remifentanil

The noninvasive ventilation intolerated patients was sedated by remifentanil.

DRUG

Dexmedetomidine

The noninvasive ventilation intolerated patients was sedated by dexmeditomidine.

Sponsors & Collaborators

  • Shanghai Zhongshan Hospital

    lead OTHER

Principal Investigators

  • Guo-wei Tu, PhD · Fudan University

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-01-01
Primary Completion
2019-03-31
Completion
2019-03-31
FDA Drug
Yes

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03395886 on ClinicalTrials.gov